Evidence map›Paper›PMID 25825451›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.

Noé Rodríguez-Rodríguez, Sokratis A Apostolidis, Pablo Penaloza-MacMaster, José Manuel Martín Villa, Dan H Barouch, George C Tsokos, José C Crispín

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. (TCRαβCells · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Characterization and effective expansion of CD4Molecular therapy. Methods & clinical development · 2025
    Article
  7. Review
  8. CD3Frontiers in immunology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Frontiers in immunology · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Helios Expression Is Downregulated on CD8Frontiers in immunology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Noé Rodríguez-RodríguezDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215; Departamento de Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, 28040, Spain;
Sokratis A ApostolidisDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215;
Pablo Penaloza-MacMasterCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and.
José Manuel Martín VillaDepartamento de Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, 28040, Spain;
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139.
George C TsokosDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215; carlos.crispina@incmnsz.mx gtsokos@bidmc.harvard.edu.
José C CrispínDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215; carlos.crispina@incmnsz.mx gtsokos@bidmc.harvard.edu.

Funding

Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
Expanded Double Negative T cells in SLE.R01AI085567 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TSOKOS, GEORGE C · 2010 to 2025
$6.8M
PP2A B-beta a novel apoptosis regulatorR21AR063262 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CRISPIN, JOSE CARLOS · 2012 to 2013
$418k
NIAID NIH HHS R01 AI085567NIAID NIH HHS T32 AI007387NIAMS NIH HHS R21 AR063262
6 · The paper itself

Abstract

TCR-αβ(+) double-negative (DN; CD4(-)CD8(-)) T cells represent a poorly understood cellular subset suggested to contribute to the pathogenesis of the autoimmune disease systemic lupus erythematosus. DN T cells have been proposed to derive from CD8(+) cells. However, the conditions that govern the loss of CD8 expression after Ag encounter are unknown. In this study, we tracked the fate of CD8 T cells from transgenic TCR mice exposed to their cognate Ags as self or in the context of infection. We demonstrate that CD8 T cells lose CD8 expression and become DN only when cognate Ag is sensed as self. This process is restricted to tissues where the Ag is present. We also show that DN T cells derived from self-reactive CD8 cells express the inhibitory molecules PD-1 and Helios. These molecules identify a subset of DN T cells in normal mice. A similar population expands when CD8 T cells from repertoires enriched in self-reactive cells (Aire-deficient) are transferred into cognate hosts. Collectively, our data suggest that a subset of DN T cells, identified by the expression of PD-1 and Helios, represent self-reactive cells. Our results provide an explanation for the origin of DN T cells and introduce CD8 loss as a process associated with self-Ag encounter.

Indexed as

AnimalsCD8-Positive T-LymphocytesDNA-Binding ProteinsMiceMice, NudeProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell, alpha-betaT-Lymphocyte SubsetsTranscription FactorsDNA-Binding ProteinsPdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, Antigen, T-Cell, alpha-betaTranscription FactorsZfpn1a2 protein, mouse

Identifiers

PMID25825451
PMCPMC4503929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.